Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sporadic Inclusion Body Myositis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00001261
What this trial is testing

Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies

Who this might be right for
DermatomyositisInclusion Body MyositisPolymyositis
National Institute of Neurological Disorders and Stroke (NINDS) 120
Large-scale testing (Phase 3)Study completedNCT00443222
What this trial is testing

Treatment With TNF Blockade, Infliximab, in Patients With Myositis

Who this might be right for
Refractory Myositis
Karolinska Institutet
Early research (Phase 1)Study completedNCT01519349
What this trial is testing

Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis

Who this might be right for
Becker Muscular DystrophySporadic Inclusion Body Myositis
Nationwide Children's Hospital 15
Not applicableStudy completedNCT03299335
What this trial is testing

Molecular Profile of the Evolution of Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Centre Hospitalier Universitaire de Nice 4
Not applicableActive Not RecruitingNCT05046821
What this trial is testing

Sporadic Inclusion Body Myositis Natural History Study

Who this might be right for
Sporadic Inclusion Body MyositisInclusion Body Myositis
University of California, Irvine 150
Not applicableActive Not RecruitingNCT01171573
What this trial is testing

Investigating Genes in Patients With Polymyositis and Dermatomyositis

Who this might be right for
Myositis
Northern Care Alliance NHS Foundation Trust 1,000
Testing effectiveness (Phase 2)Ended earlyNCT01801917
What this trial is testing

Efficacy and Tolerability of BAF312 in Patients With Polymyositis

Who this might be right for
Polymyositis
Novartis Pharmaceuticals 14
Not applicableUnknownNCT05272969
What this trial is testing

Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease

Who this might be right for
Pompe Disease (Late-onset)Inclusion Body MyositisSpinal Muscular Atrophy Type 3+1 more
LMU Klinikum 95
Very early researchStudy completedNCT00802815
What this trial is testing

Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Washington University School of Medicine 20
Not applicableLooking for participantsNCT07823101
What this trial is testing

Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis

Who this might be right for
IBMInclusion Body MyositisMyopathy+3 more
Johns Hopkins University 30
Not applicableStudy completedNCT02810028
What this trial is testing

Acceptance and Commitment Therapy for Muscle Disease

Who this might be right for
Muscle Diseases
King's College Hospital NHS Trust 155
Large-scale testing (Phase 3)Study completedNCT02573467
What this trial is testing

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 211
Testing effectiveness (Phase 2)Ended earlyNCT01148810
What this trial is testing

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis

Who this might be right for
PolymyositisDermatomyositis
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT00079768
What this trial is testing

Alemtuzumab to Treat Sporadic Inclusion Body Myositis

Who this might be right for
Myositis, Inclusion Body
National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableActive Not RecruitingNCT06153108
What this trial is testing

Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time

Who this might be right for
Inclusion Body Myositis
University of Kansas Medical Center 20